Peer-Reviewed Journal Details
Mandatory Fields
Finn, DP,Forte, KCF,Beckett, SRG,Baxter, JA,Ansell, L,Marsden, CA,Chapman, V
2007
August
European Journal Of Pharmacology
The effects of pharmacological blockade of the 5-HT6 receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats
Published
()
Optional Fields
5-HT6 receptor SB-271046 pain stress corticosterone locomotor activity ANTISENSE OLIGONUCLEOTIDES PERIAQUEDUCTAL GRAY SEROTONIN ANTAGONIST ANALGESIA SB-271046 SCHIZOPHRENIA EXPRESSION NEURONS MODELS
569
59
63
5-hydroxytryptamine (5-HT) mediates behavioural and neuroendocrine responses to noxious or stressful stimuli. 5-HT6 receptors are expressed in brain regions involved in nociceptive processing, however, their role in nociception is unknown. Here we demonstrate that acute, systemic administration of the 5-HT6 receptor antagonist, 5-chloro-N-(4-methoxy-3-benzothio-phenesulfonamide (SB-271046), reduces formalin-evoked nociceptive behaviour and increases plasma corticosterone. SB-271046 dose-dependently reduced pre-formalin distance moved, rearing, grooming and defecation. These data provide the first evidence for 5-HT6 receptor-mediated regulation of nociception and hypothalamopituitary-adrenal axis activity in a model of persistent pain although effects on locomotor activity demand that the putative antinociceptive effect of SB-271046 be interpreted with some caution. (c) 2007 Elsevier B.V. All rights reserved.
DOI 10.1016/j.ejphar.2007.05.020
Grant Details
Publication Themes